Skip to main content

Our Clinical Commitment clinic

Revival Research Institute is collaborating with prominent Pharmaceutical sponsors and contract research organization (CROs) for phase I, II and III clinical studies. To bring CRO clinical trials closer to the patient, our specialized team combines fully integrated clinical insight, innovative technologies and core excellence

Therapeutic Approach from Start to Solution

From monitoring drug to drug interactions to conducting phase I, II and III, single ascending dose/multiple ascending dose research studies, our processes are streamlined to be efficient, while maintaining complete data integrity. We at Revival Research Institute have a vigorous experience with an array of investigational products with variant modes of delivery. Our prime focus is to maintain consistency between all processes and submission as well as to cover all therapeutic areas and indications.

Our Patient Recruitment

Our ingenious team provides technical and efficient clinical trial recruitment processes for sponsors and other contract research organization. From small human trials to substantial large collaborations, our experience has been proven to be successful through long-term partnership with diverse delivery models in multiple locations specifically, Southfield Michigan, Arizona and Texas.

We Honor Our Commitment

Our first concern is to ensure that our sponsors, be it pharmaceutical companies or contract research organization (CRO), are completely satisfied with the data. We aim to abide by the current Good Clinical Practices (GCP) guidelines. Our specialized research team will offer the finest service possible by ensuring that all study protocols are fully enforced, all regulatory documentations are submitted on time, and that a clear channel of communication regarding patient safety and data integrity is maintained.

At Revival Research Institute

As a sponsor or contract research organization, collaboration with Revival Research Institute will ensure that all research studies will be conducted by a quality-driven, safety-focused, and data-compliant research staff. Our key focus remains on:

  • Making sure all regional, state, and federal rules and regulations are strictly followed.
  • Maintaining that all employees are HIPAA-compliant, as well as GCP and IATA-certified
  • Multicenter studies that utilizes central IRB
  • Creating, implementing, and executing standard operating procedures at all sites
  • Calibrating and updating all equipment available at the research sites
  • Facilitating site initiation visit once the study sponsor has chosen the site for the trial